Abstract
The interactions between therapeutics and their targets are an important part of the drug development process. To counter the cost, time and accuracy related issues, novel and efficient DL algorithms are required. These approaches have proven successful in quickly identifying and predicting possible drug interactions. Here, we examine computational strategies for predicting drug interactions in the context of drug development, focusing on artificial intelligence-based approaches. We start by providing a succinct overview of deep learning in drug development and drug interactions. Next, we review and evaluate AI-based methods used to forecast Drug–Target Interactions, drug–drug interactions, drug–disease interactions, and ploy-pharmacy side effects, including both sequential and graph-based modern DL algorithms. Lastly, we examine databases with their brief description and sources that are frequently utilized to research drug interactions.
Similar content being viewed by others
Data availability
No data was generated.
References
Gawehn, E., Hiss, J.A., Schneider, G.: Deep learning in drug discovery. Mol. Inform. 35(1), 3–14 (2016). https://doi.org/10.1002/minf.201501008
Wen, M., et al.: Deep-learning-based drug-target interaction prediction. J. Proteome Res. 16(4), 1401–1409 (2017). https://doi.org/10.1021/acs.jproteome.6b00618
Shukla, P.K., et al.: Efficient prediction of drug–drug interaction using deep learning models. IET Syst. Biol. 14(4), 211–216 (2020). https://doi.org/10.1049/iet-syb.2019.0116
K. Preuer, G. Klambauer, F. Rippmann, S. Hochreiter, T. Unterthiner, Interpretable deep learning in drug discovery. In: Lect. Notes Comput. Sci. (including Subser. Lect. Notes Artif. Intell. Lect. Notes Bioinformatics), vol. 11700 LNCS, pp. 331–345 (2019). https://doi.org/10.1007/978-3-030-28954-6_18.
Chen, H., Engkvist, O., Wang, Y., Olivecrona, M., Blaschke, T.: The rise of deep learning in drug discovery. Drug Discov. TodayDiscov. Today 23(6), 1241–1250 (2018). https://doi.org/10.1016/j.drudis.2018.01.039
Lavecchia, A.: Deep learning in drug discovery: opportunities, challenges and future prospects. Drug Discov. TodayDiscov. Today 24(10), 2017–2032 (2019). https://doi.org/10.1016/j.drudis.2019.07.006
Askr, H., Elgeldawi, E., Aboul Ella, H., Elshaier, Y.A.M.M., Gomaa, M.M., Hassanien, A.E.: Deep learning in drug discovery: an integrative review and future challenges, no. 0123456789. Springer, Netherlands (2022). https://doi.org/10.1007/s10462-022-10306-1
Srinivasu, P.N., Shafi, J., Krishna, T.B., Sujatha, C.N., Praveen, S.P., Ijaz, M.F.: Using recurrent neural networks for predicting type-2 diabetes from genomic and tabular data. Diagnostics (2022). https://doi.org/10.3390/diagnostics12123067
Praveen, S.P., Srinivasu, P.N., Shafi, J., Wozniak, M., Ijaz, M.F.: ResNet-32 and FastAI for diagnoses of ductal carcinoma from 2D tissue slides. Sci. Rep. 12(1), 1–16 (2022). https://doi.org/10.1038/s41598-022-25089-2
Ghosh, S., Kim, S.K., Ijaz, M.F., Singh, P.K., Mahmud, M.: Classification of mental stress from wearable physiological sensors using image-encoding-based deep neural network. Biosensors (2022). https://doi.org/10.3390/bios12121153
Subhan, F., et al.: Cancerous tumor controlled treatment using search heuristic (GA)-based sliding mode and synergetic controller. Cancers (Basel) (2022). https://doi.org/10.3390/cancers14174191
Shafi, J., Woźniak, M., Sujatha, R.: 6G Driven fast computational networking framework for healthcare applications. IEEE Access 10(August), 94235–94248 (2022). https://doi.org/10.1109/ACCESS.2022.3203061
Vallianatou, T., Giaginis, C., Tsantili-Kakoulidou, A.: The impact of physicochemical and molecular properties in drug design: Navigation in the ‘Drug-Like’ chemical space. Adv. Exp. Med. Biol. 822, 187–194 (2015). https://doi.org/10.1007/978-3-319-08927-0_21
Lomenick, B.E.: Small molecule target identification using drug affinity responsive target stability (DARTS), vol. 1263, pp. 1–115. Springer, New York (2013). https://doi.org/10.1007/978-1-4939-2269-7
Glassman, P.M., Muzykantov, V.R.: Pharmacokinetic and pharmacodynamic properties of drug delivery systems. J. Pharmacol Exp. Ther.Pharmacol Exp. Ther. 370(3), 570–580 (2019). https://doi.org/10.1124/jpet.119.257113
Alshammari, T.M.: Drug safety: the concept, inception and its importance in patients’ health. Saudi Pharm. J. 24(4), 405–412 (2016). https://doi.org/10.1016/j.jsps.2014.04.008
Naqvi, A.A.T., Mohammad, T., Hasan, G.M., Hassan, M.I.: Advancements in docking and molecular dynamics simulations towards ligand-receptor interactions and structure-function relationships. Curr. Top. Med. Chem.. Top. Med. Chem. 18(20), 1755–1768 (2019). https://doi.org/10.2174/1568026618666181025114157
Rambhade, S., Chakarborty, A., Shrivastava, A., Patil, U.K., Rambhade, A.: A survey on polypharmacy and use of inappropriate medications. Toxicol. Int.. Int. 19(1), 68–73 (2012). https://doi.org/10.4103/0971-6580.94506
Percha, B., Altman, R.B.: Informatics confronts drug–drug interactions. Trends Pharmacol. Sci.Pharmacol. Sci. 34(3), 178–184 (2013). https://doi.org/10.1016/j.tips.2013.01.006
Huang, K., Fu, T., Glass, L.M., Zitnik, M., Xiao, C., Sun, J.: DeepPurpose: A deep learning library for drug–target interaction prediction. Bioinformatics 36(22–23), 5545–5547 (2020). https://doi.org/10.1093/bioinformatics/btaa1005
Wang, L., et al.: A computational-based method for predicting drug–target interactions by using stacked autoencoder deep neural network. J. Comput. Biol.Comput. Biol. 25(3), 361–373 (2018). https://doi.org/10.1089/cmb.2017.0135
You, J., Mcleod, R.D., Hu, P.: Predicting drug–target interaction network using deep learning model. Comput. Biol. Chem.. Biol. Chem. 80(March), 90–101 (2019). https://doi.org/10.1016/j.compbiolchem.2019.03.016
Mei, S., Zhang, K.: A machine learning framework for predicting drug–drug interactions. Sci. Rep. 11(1), 1–12 (2021). https://doi.org/10.1038/s41598-021-97193-8
Yamanishi, Y., Araki, M., Gutteridge, A., Honda, W., Kanehisa, M.: Prediction of drug–target interaction networks from the integration of chemical and genomic spaces. Bioinformatics 24(13), i232–i240 (2008)
Perlman, L., Gottlieb, A., Atias, N., Ruppin, E., Sharan, R.: Combining drug and gene similarity measures for drug–target elucidation. J. Comput. Biol.Comput. Biol. 18(2), 133–145 (2011)
Peng, H., Long, F., Ding, C.: Feature selection based on mutual information criteria of max-dependency, max-relevance, and min-redundancy. IEEE Trans. Pattern Anal. Mach. Intell.Intell. 27(8), 1226–1238 (2005)
Shi, J.-Y., Yiu, S.-M.: SRP: A concise non-parametric similarity-rank-based model for predicting drug–target interactions. In: 2015 IEEE International Conference on Bioinformatics and Biomedicine (BIBM), pp. 1636–1641 (2015)
Lt, K.: To err is human: building a safer health system. Inst. Med. Comm. Qual. Heal. Care Am. (2000)
Takarabe, M., Kotera, M., Nishimura, Y., Goto, S., Yamanishi, Y.: Drug target prediction using adverse event report systems: a pharmacogenomic approach. Bioinformatics 28(18), i611–i618 (2012)
Wang, Y.C., Zhang, C.H., Deng, N.Y., Wang, Y.: Kernel-based data fusion improves the drug–protein interaction prediction. Comput. Biol. Chem.. Biol. Chem. 35(6), 353–362 (2011). https://doi.org/10.1016/j.compbiolchem.2011.10.003
Pahikkala, T., et al.: Toward more realistic drug–target interaction predictions. Brief. Bioinform.Bioinform. 16(2), 325–337 (2015)
Xia, Z., Wu, L.-Y., Zhou, X., Wong, S.T.C.: Semi-supervised drug–protein interaction prediction from heterogeneous biological spaces. BMC Syst. Biol. 4(2), 1–16 (2010)
Jacob, L., Vert, J.-P.: Protein-ligand interaction prediction: an improved chemogenomics approach. Bioinformatics 24(19), 2149–2156 (2008)
Bock, J.R., Gough, D.A.: Virtual screen for ligands of orphan G protein-coupled receptors. J. Chem. Inf. Model. 45(5), 1402–1414 (2005)
Lavecchia, A.: Machine-learning approaches in drug discovery: methods and applications. Drug Discov. TodayDiscov. Today 20(3), 318–331 (2015)
He, Z., et al.: Predicting drug–target interaction networks based on functional groups and biological features. PLoS ONE 5(3), e9603 (2010)
Yuan, Q., Gao, J., Wu, D., Zhang, S., Mamitsuka, H., Zhu, S.: DrugE-Rank: improving drug–target interaction prediction of new candidate drugs or targets by ensemble learning to rank. Bioinformatics 32(12), i18–i27 (2016)
Ezzat, A., Wu, M., Li, X., Kwoh, C.-K.: Computational prediction of drug–target interactions via ensemble learning. In: Comput Methods Drug Repurposing, pp. 239–254. Springer, New York (2019)
Wang, L., You, Z.-H., Chen, X., Yan, X., Liu, G., Zhang, W.: RFDT: a rotation forest-based predictor for predicting drug-target interactions using drug structure and protein sequence information. Curr. Protein Pept. Sci.. Protein Pept. Sci. 19(5), 445–454 (2016). https://doi.org/10.2174/1389203718666161114111656
Huang, Y., You, Z., Chen, X.: A systematic prediction of drug-target interactions using molecular fingerprints and protein sequences. Curr. Protein Pept. Sci.. Protein Pept. Sci. 19(5), 468–478 (2018). https://doi.org/10.2174/1389203718666161122103057
Nascimento, A.C.A., Prudêncio, R.B.C., Costa, I.G.: A multiple kernel learning algorithm for drug–target interaction prediction. BMC Bioinformatics 17(1), 1–16 (2016). https://doi.org/10.1186/s12859-016-0890-3
Cheng, F., et al.: Prediction of drug–target interactions and drug repositioning via network-based inference. PLoS Comput. Biol. Comput. Biol. 8(5), e1002503 (2012)
Ji, B.Y., You, Z.H., Jiang, H.J., Guo, Z.H., Zheng, K.: Prediction of drug–target interactions from multi-molecular network based on LINE network representation method. J. Transl. Med. 18(1), 1–11 (2020). https://doi.org/10.1186/s12967-020-02490-x
An, J.Y., Meng, F.R., Yan, Z.J.: An efficient computational method for predicting drug–target interactions using weighted extreme learning machine and speed up robot features. BioData Min. 14(1), 1–17 (2021). https://doi.org/10.1186/s13040-021-00242-1
Zhao, Z., Huang, W., Zhan, X., Pan, J., Huang, Y.: An ensemble learning-based method for inferring drug–target interactions combining protein sequences and drug fingerprints, vol. 2021 (2021)
Yue, Y., He, S.: DTI-HeNE: a novel method for drug–target interaction prediction based on heterogeneous network embedding. BMC Bioinform. 22(1), 1–20 (2021). https://doi.org/10.1186/s12859-021-04327-w
Chen, X., Liu, M.-X., Yan, G.-Y.: Drug–target interaction prediction by random walk on the heterogeneous network. Mol. Biosyst.Biosyst. 8(7), 1970–1978 (2012)
Köhler, S., Bauer, S., Horn, D., Robinson, P.N.: Walking the interactome for prioritization of candidate disease genes. Am. J. Hum. Genet. 82(4), 949–958 (2008)
Gawehn, E., Hiss, J.A., Schneider, G.: Deep learning in drug discovery. Mol. Inform. 35(1), 3–14 (2016)
Ekins, S.: The next era: deep learning in pharmaceutical research. Pharm. Res. 33(11), 2594–2603 (2016)
Napolitano, F., et al.: Drug repositioning: a machine-learning approach through data integration. J. Cheminform. 5(1), 1–9 (2013)
Zong, N., Kim, H., Ngo, V., Harismendy, O.: Deep mining heterogeneous networks of biomedical linked data to predict novel drug–target associations. Bioinformatics 33(15), 2337–2344 (2017)
Eslami Manoochehri, H., Nourani, M.: Drug–target interaction prediction using semi-bipartite graph model and deep learning. BMC Bioinform. 21(Suppl 4), 1–16 (2020). https://doi.org/10.1186/s12859-020-3518-6
Lee, I., Keum, J., Nam, H.: DeepConv-DTI: Prediction of drug–target interactions via deep learning with convolution on protein sequences. PLoS Comput. Biol. Comput. Biol. 15(6), e1007129 (2019)
Öztürk, H., Özgür, A., Ozkirimli, E.: DeepDTA: Deep drug–target binding affinity prediction. Bioinformatics 34(17), i821–i829 (2018). https://doi.org/10.1093/bioinformatics/bty593
Gao, K.Y., Fokoue, A., Luo, H., Iyengar, A., Dey, S., Zhang, P.: Interpretable drug target prediction using deep neural representation. IJCAI 2018, 3371–3377 (2018)
Redkar, S., Mondal, S., Joseph, A., Hareesha, K.S.: A machine learning approach for drug–target interaction prediction using wrapper feature selection and class balancing. Mol. Inform. (2020). https://doi.org/10.1002/minf.201900062
Wang, Y., You, Z., Yang, S., Yi, H., Chen, Z., Zheng, K.: A deep learning-based method for drug–target interaction prediction based on long short-term memory neural network. BMC Med. Inform. Decis. Mak.Decis. Mak. 20(Suppl 2), 1–9 (2020). https://doi.org/10.1186/s12911-020-1052-0
Thafar, M.A., et al.: DTi2Vec: drug–target interaction prediction using network embedding and ensemble learning. J. Cheminform. 13(1), 1–18 (2021). https://doi.org/10.1186/s13321-021-00552-w
Zhang, Y., Jiang, Z., Chen, C., Wei, Q., Gu, H., Yu, B.: DeepStack—DTIs : predicting drug—target interactions using LightGBM feature selection and deep—stacked ensemble classifi. Interdiscip. Sci. Comput. Life Sci. (2021). https://doi.org/10.1007/s12539-021-00488-7
Sun, J., Lu, Y., Cui, L., Fu, Q., Wu, H., Chen, J.: A method of optimizing weight allocation in data integration based on Q-learning for drug-target interaction prediction. Front. Cell Dev. Biol. 10(March), 1–10 (2022). https://doi.org/10.3389/fcell.2022.794413
Ye, Q., Zhang, X., Lin, X.: Drug–target interaction prediction via multiple classification strategies. BMC Bioinform. 22, 1–18 (2022). https://doi.org/10.1186/s12859-021-04366-3
Agarwal, S., Dugar, D., Sengupta, S.: Ranking chemical structures for drug discovery: a new machine learning approach. J. Chem. Inf. Model. 50(5), 716–731 (2010)
Burges, C.J.C.: From ranknet to lambdarank to lambdamart: an overview. Learning 11(23–581), 81 (2010)
Kuang, Q., et al.: A kernel matrix dimension reduction method for predicting drug–target interaction. Chemom. Intell. Lab. Syst.. Intell. Lab. Syst. 162, 104–110 (2017)
Wan, F., Hong, L., Xiao, A., Jiang, T., Zeng, J.: NeoDTI: neural integration of neighbor information from a heterogeneous network for discovering new drug–target interactions. Bioinformatics 35(1), 104–111 (2019)
Ban, T., Ohue, M., Akiyama, Y.: NRLMFβ: Beta-distribution-rescored neighborhood regularized logistic matrix factorization for improving the performance of drug–target interaction prediction. Biochem. Biophys. Rep. 18, 100615 (2019)
Luo, Y., et al.: A network integration approach for drug–target interaction prediction and computational drug repositioning from heterogeneous information. Nat. Commun.Commun. 8(1), 573 (2017)
Zheng, X., Ding, H., Mamitsuka, H., Zhu, S.: Collaborative matrix factorization with multiple similarities for predicting drug–target interactions. In: Proceedings of the 19th ACM SIGKDD International Conference on Knowledge Discovery and Data Mining, pp. 1025–1033 (2013)
Zhao, T., Hu, Y., Valsdottir, L.R., Zang, T., Peng, J.: Identifying drug–target interactions based on graph convolutional network and deep neural network. Brief. Bioinformat. (2020). https://doi.org/10.1093/bib/bbaa044
Yang, Z., Zhong, W., Zhao, L., Yu-ChianChen, C.: MGraphDTA: deep multiscale graph neural network for explainable drug–target binding affinity prediction. Chem. Sci. 13(3), 816–833 (2022). https://doi.org/10.1039/d1sc05180f
Peng, J., et al.: An end-to-end heterogeneous graph representation learning-based framework for drug–target interaction prediction. Brief. Bioinform.Bioinform. 22(5), 1–9 (2021). https://doi.org/10.1093/bib/bbaa430
Zhang, R., Wang, Z., Wang, X., Meng, Z., Cui, W.: MHTAN-DTI: Metapath-based hierarchical transformer and attention network for drug–target interaction prediction. Brief. Bioinform.Bioinform. 24(2), bbad079 (2023)
Boezer, M, Tavakol, M., Sajadi, Z.: FastDTI: drug–target interaction prediction using multimodality and transformers. In: Proceedings of the Northern Lights Deep Learning Workshop, vol. 4 (2023)
Wu, H., et al.: AttentionMGT-DTA: a multi-modal drug–target affinity prediction using graph transformer and attention mechanism. Neural Netw.Netw. 169, 623–636 (2024)
Liu, J., et al.: Drug–target interaction prediction via combining transformer and graph neural networks
Feng, Y., Zhang, S.: Yue-Hua—DPDDI a deep predictor for drug–drug interactions.pdf, pp. 1–15 (2020)
Vilar, S., Harpaz, R., Uriarte, E., Santana, L., Rabadan, R., Friedman, C.: Drug—drug interaction through molecular structure similarity analysis. J. Am. Med. Informat. Assoc. 19(6), 1066–1074 (2012)
Ferdousi, R., Safdari, R., Omidi, Y.: Computational prediction of drug–drug interactions based on drugs functional similarities. J. Biomed. Inform. 70, 54–64 (2017)
Gottlieb, A., Stein, G.Y., Oron, Y., Ruppin, E., Sharan, R.: INDI: a computational framework for inferring drug interactions and their associated recommendations. Mol. Syst. Biol. 8(1), 592 (2012)
Li, P., et al.: Large-scale exploration and analysis of drug combinations. Bioinformatics 31(12), 2007–2016 (2015)
Shi, J.-Y., Gao, K., Shang, X.-Q., Yiu, S.-M.: LCM-DS: a novel approach of predicting drug–drug interactions for new drugs via Dempster-Shafer theory of evidence. In: 2016 IEEE International Conference on Bioinformatics and Biomedicine (BIBM), pp. 512–515 (2016)
Zhang, Y., Zheng, W., Lin, H., Wang, J., Yang, Z., Dumontier, M.: Data and text mining drug–drug interaction extraction via hierarchical RNNs on sequence and shortest dependency paths. Bioinformatics 34(017), 828–835 (2018). https://doi.org/10.1093/bioinformatics/btx659
Lim, S., Lee, K., Kang, J.: Drug drug interaction extraction from the literature using a recursive neural network. PLoS ONE 13(1), 1–17 (2018). https://doi.org/10.1371/journal.pone.0190926
Loss, F., et al.: Drug–drug interaction extraction via recurrent hybrid convolutional neural networks with. Entropy (2019). https://doi.org/10.3390/e21010037
Huang, D., Jiang, Z., Zou, L., Li, L.: Drug–drug interaction extraction from biomedical literature using support vector machine and long short term memory networks. Inf. Sci. (Ny) 415–416, 100–109 (2017). https://doi.org/10.1016/j.ins.2017.06.021
Lotfi Shahreza, M., Ghadiri, N., Mousavi, S.R., Varshosaz, J., Green, J.R.: A review of network-based approaches to drug repositioning. Brief. Bioinform.Bioinform. 19(5), 878–892 (2018)
Zhang, Y., et al.: Leveraging syntactic and semantic graph kernels to extract pharmacokinetic drug drug interactions from biomedical literature. BMC Syst. Biol. (2016). https://doi.org/10.1186/s12918-016-0311-2
Zheng, W., et al.: A graph kernel based on context vectors for extracting drug–drug interactions. J. Biomed. Inform. 61, 34–43 (2016). https://doi.org/10.1016/j.jbi.2016.03.014
Han, X., Xie, R., Li, X., Li, J.: SmileGNN: drug-drug interaction prediction based on the SMILES and graph neural network. Life (2022). https://doi.org/10.3390/life12020319
Vilar, S., Uriarte, E., Santana, L., Tatonetti, N.P., Friedman, C.: Detection of drug–drug interactions by modeling interaction profile fingerprints. PLoS ONE 8(3), e58321 (2013)
Rohani, N., Eslahchi, C., Katanforoush, A.: ISCMF: Integrated similarity-constrained matrix factorization for drug–drug interaction prediction. Netw. Model. Anal. Heal. Informat. Bioinform. 9, 1–8 (2020)
Shtar, G., Rokach, L., Shapira, B.: Detecting drug–drug interactions using artificial neural networks and classic graph similarity measures. PLoS ONE 14(8), e0219796 (2019)
Yu, H., et al.: Predicting and understanding comprehensive drug–drug interactions via semi-nonnegative matrix factorization. BMC Syst. Biol. 12(1), 101–110 (2018)
Shi, J.-Y., et al.: TMFUF: a triple matrix factorization-based unified framework for predicting comprehensive drug–drug interactions of new drugs. BMC Bioinform. 19(14), 27–37 (2018)
Shi, J.Y., Mao, K.T., Yu, H., Yiu, S.M.: Detecting drug communities and predicting comprehensive drug–drug interactions via balance regularized semi-nonnegative matrix factorization. J. Cheminform. 11(1), 1–16 (2019). https://doi.org/10.1186/s13321-019-0352-9
Zhang, P., Wang, F., Hu, J., Sorrentino, R.: Label propagation prediction of drug–drug interactions based on clinical side effects. Sci. Rep. 5(1), 12339 (2015)
Zhang, W., Chen, Y., Liu, F., Luo, F., Tian, G., Li, X.: Predicting potential drug–drug interactions by integrating chemical, biological, phenotypic and network data. BMC Bioinform. 18, 1–12 (2017)
Cheng, F., Zhao, Z.: “Machine learning-based prediction of drug–drug interactions by integrating drug phenotypic, therapeutic, chemical, and genomic properties. J. Am. Med. Informat. Assoc. (2014). https://doi.org/10.1136/amiajnl-2013-002512
Deepika, S.S., Geetha, T.V.: A meta-learning framework using representation learning to predict drug–drug interaction. J. Biomed. Inform. 84(June), 136–147 (2018). https://doi.org/10.1016/j.jbi.2018.06.015
Wang, T. et al.: A multi-scale feature fusion model based on biological knowledge graph and transformer-encoder for drug–drug interaction prediction. bioRxiv, pp. 2001–2024 (2024)
Tari, L., Anwar, S., Liang, S., Cai, J., Baral, C.: Discovering drug–drug interactions: a text-mining and reasoning approach based on properties of drug metabolism. Bioinformatics 26(18), i547–i553 (2010)
Tatonetti, N.P., Ye, P.P., Daneshjou, R., Altman, R.B.: Data-driven prediction of drug effects and interactions. Sci. Transl. Med. 4(125), 125ra31-125ra31 (2012)
Kolchinsky, A., Lourenço, A., Li, L., Rocha, L.M.: Evaluation of linear classifiers on articles containing pharmacokinetic evidence of drug–drug interactions. Biocomput. World Sci. 2013, 409–420 (2013)
Liu, S., Tang, B., Chen, Q., Wang, X.: Drug–drug interaction extraction via convolutional neural networks. Comput. Math. Methods Med.. Math. Methods Med. (2016). https://doi.org/10.1155/2016/6918381
Zhang, C., Lu, Y., Zang, T.: CNN-DDI: a learning-based method for predicting drug–drug interactions using convolution neural networks. BMC Bioinform. 23, 1–12 (2022). https://doi.org/10.1186/s12859-022-04612-2
Jarada, T.N., Rokne, J.G., Alhajj, R.: SNF-NN: computational method to predict drug–disease interactions using similarity network fusion and neural networks. BMC Bioinform. 22(1), 1–20 (2021)
Ye, Q., et al.: A unified drug–target interaction prediction framework based on knowledge graph and recommendation system. Nat. Commun.Commun. 12(1), 6775 (2021)
Luo, H., et al.: Drug repositioning based on comprehensive similarity measures and Bi-Random walk algorithm. Bioinformatics 32(17), 2664–2671 (2016). https://doi.org/10.1093/bioinformatics/btw228
Zhang, W., et al.: Predicting drug–disease associations by using similarity constrained matrix factorization. BMC Bioinformat. 19(1), 1–12 (2018). https://doi.org/10.1186/s12859-018-2220-4
Jiang, H.J., Huang, Y.A., You, Z.H.: SAEROF: an ensemble approach for large-scale drug–disease association prediction by incorporating rotation forest and sparse autoencoder deep neural network. Sci. Rep. 10(1), 1–11 (2020). https://doi.org/10.1038/s41598-020-61616-9
Wu, C., Gudivada, R.C., Aronow, B.J., Jegga, A.G.: Computational drug repositioning through heterogeneous network clustering. BMC Syst. Biol. 7, 1–9 (2013)
Wang, W., Yang, S., Zhang, X., Li, J.: Drug repositioning by integrating target information through a heterogeneous network model. Bioinformatics 30(20), 2923–2930 (2014). https://doi.org/10.1093/bioinformatics/btu403
Martinez, V., Navarro, C., Cano, C., Fajardo, W., Blanco, A.: DrugNet: network-based drug–disease prioritization by integrating heterogeneous data. Artif. Intell. Med.. Intell. Med. 63(1), 41–49 (2015)
Liu, H., Song, Y., Guan, J., Luo, L., Zhuang, Z.: Inferring new indications for approved drugs via random walk on drug–disease heterogenous networks. BMC Bioinform. 17, 269–277 (2016)
Wang, Y., Guo, M., Ren, Y., Jia, L., Yu, G.: Drug repositioning based on individual bi-random walks on a heterogeneous network. BMC Bioinform. 20(15), 1–13 (2019)
Wu, G., Liu, J., Yue, X.: Prediction of drug–disease associations based on ensemble meta paths and singular value decomposition. BMC Bioinform. 20(3), 1–13 (2019)
Xie, G., et al.: Bgmsdda: a bipartite graph diffusion algorithm with multiple similarity integration for drug–disease association prediction. Mol. Omi. 17(6), 997–1011 (2021)
Zhao, B.W., You, Z.H., Wong, L., Zhang, P., Li, H.Y., Wang, L.: MGRL: predicting drug-disease associations based on multi-graph representation learning. Front. Genet. (2021). https://doi.org/10.3389/fgene.2021.657182
Jarada, T.N., Rokne, J.G., Alhajj, R.: SNF-NN: computational method to predict drug–disease interactions using similarity network fusion and neural networks. BMC Bioinform. 22(1), 1–20 (2021). https://doi.org/10.1186/s12859-020-03950-3
Luo, H., Li, M., Wang, S., Liu, Q., Li, Y., Wang, J.: Computational drug repositioning using low-rank matrix approximation and randomized algorithms. Bioinformatics 34(11), 1904–1912 (2018)
Yang, M., Luo, H., Li, Y., Wu, F.-X., Wang, J.: Overlap matrix completion for predicting drug–associated indications. PLoS Comput. Biol. Comput. Biol. 15(12), e1007541 (2019)
Zhang, W., Xu, H., Li, X., Gao, Q., Wang, L.: DRIMC: an improved drug repositioning approach using Bayesian inductive matrix completion. Bioinformatics 36(9), 2839–2847 (2020)
Yang, M., Wu, G., Zhao, Q., Li, Y., Wang, J.: Computational drug repositioning based on multi-similarities bilinear matrix factorization. Brief. Bioinform.Bioinform. 22(4), bbaa267 (2021)
Jamali, A.A., Tan, Y., Kusalik, A., Wu, F.-X.: NTD-DR: nonnegative tensor decomposition for drug repositioning. PLoS ONE 17(7), e0270852 (2022)
Zeng, X., Zhu, S., Liu, X., Zhou, Y., Nussinov, R., Cheng, F.: deepDR: a network-based deep learning approach to in silico drug repositioning. Bioinformatics 35(24), 5191–5198 (2019)
Yang, X., Zamit, L., Liu, Y., He, J.: Additional neural matrix factorization model for computational drug repositioning. BMC Bioinform. 20, 1–11 (2019)
Zhou, R., Lu, Z., Luo, H., Xiang, J., Zeng, M., Li, M.: NEDD: a network embedding based method for predicting drug–disease associations. BMC Bioinform. 21(13), 1–12 (2020)
Yu, Z., Huang, F., Zhao, X., Xiao, W., Zhang, W.: Predicting drug–disease associations through layer attention graph convolutional network. Brief. Bioinform.Bioinform. 22(4), bbaa243 (2021)
Transl, J., Jiang, H.J., You, Z.H., Huang, Y.A.: Predicting drug–disease associations via sigmoid kernel-based convolutional neural networks. J. Transl. Med. (2019). https://doi.org/10.1186/s12967-019-2127-5
C. N. Network and R. Unit: Inferring drug-related diseases based on convolutional neural network and gated. Molecules 24, 2712 (2019)
Xuan, P., Cui, H., Shen, T., Sheng, N., Zhang, T.: HeteroDualNet : a dual convolutional neural network with heterogeneous layers for drug-disease association prediction via chou ‘ s five-step rule. Front. Pharmacol.Pharmacol. 10(1), November-12 (2019). https://doi.org/10.3389/fphar.2019.01301
Li, Z., Huang, Q., Chen, X., Wang, Y., Li, J., Xie, Y.: Identification of drug-disease associations using information of molecular structures and clinical symptoms via deep convolutional neural network. Front. Chem. (2020). https://doi.org/10.3389/fchem.2019.00924
Wang, H., Zhao, S., Zhao, J., Feng, Z.: A model for predicting drug–disease associations based on dense convolutional attention network. Math. Biosci. Eng.Biosci. Eng. 18(1), 7419–7439 (2021). https://doi.org/10.3934/mbe.2021367
Tian, Z., Teng, Z., Cheng, S., Guo, M.: Computational drug repositioning using meta-path-based semantic network analysis. BMC Syst. Biol. 12(Suppl 9), 123 (2018)
Le, D.H., Nguyen-Ngoc, D.: Drug repositioning by integrating known disease-gene and drug–target associations in a semi-supervised learning model. Acta Biotheor. Biotheor. 66(4), 315–331 (2018). https://doi.org/10.1007/s10441-018-9325-z
Yi, H.C., You, Z.H., Wang, L., Su, X.R., Zhou, X., Jiang, T.H.: In silico drug repositioning using deep learning and comprehensive similarity measures. BMC Bioinform. 22, 1–14 (2021). https://doi.org/10.1186/s12859-020-03882-y
Zhang, Y., Lin, H., Yang, Z., Wang, J., Zhang, S.: A hybrid model based on neural networks for biomedical relation extraction. J. Biomed. Inform. (2018). https://doi.org/10.1016/j.jbi.2018.03.011
Stokes, J.M., et al.: A deep learning approach to antibiotic discovery. Cell 180(4), 688-702.e13 (2020). https://doi.org/10.1016/j.cell.2020.01.021
Li, J., Lu, Z.: A new method for computational drug repositioning using drug pairwise similarity. In: Proc.—2012 IEEE Int. Conf. Bioinforma. Biomed. BIBM 2012, no. 1, pp. 453–456 (2012). https://doi.org/10.1109/BIBM.2012.6392722
Fei, H., Ren, Y., Zhang, Y., Ji, D., Liang, X.: Enriching contextualized language model from knowledge graph for biomedical information extraction. Brief. Bioinform.Bioinform. 22(3), 1–14 (2021). https://doi.org/10.1093/bib/bbaa110
Mam, S., Wichadakul, D., Vateekul, P.: Drug repurposing for type 2 diabetes using combined textual and structural graph representation based on transformer. IEEE Access 11, 65711 (2023)
Liu, Y., Sang, G., Liu, Z., Pan, Y., Cheng, J., Zhang, Y.: MPTN: a message-passing transformer network for drug repurposing from knowledge graph. Comput. Biol. Med.. Biol. Med. 168, 107800 (2024)
Zitnik, M., Agrawal, M., Leskovec, J., Science, C., Biohub, C.Z.: Modeling polypharmacy side effects with graph convolutional networks. Bioinformatics (2018). https://doi.org/10.1093/bioinformatics/bty294
Masumshah, R., Aghdam, R., Eslahchi, C.: A neural network-based method for polypharmacy side effects prediction. BMC Bioinform. 22(1), 1–17 (2021). https://doi.org/10.1186/s12859-021-04298-y
Open Research Online (2016)
Mohamed, S.K., Nounu, A., Nováček, V.: Biological applications of knowledge graph embedding models. Brief. Bioinform.Bioinform. 22(2), 1679–1693 (2021). https://doi.org/10.1093/bib/bbaa012
Liu, S., An, J., Zhao, J., Zhao, S., Lv, H., Wang, S.: Drug–Target interaction prediction based on multisource information weighted fusion. Contrast Media Mol. Imaging 2021, 1 (2021)
Ezzat, A., Wu, M., Li, X.-L., Kwoh, C.-K.: Drug–target interaction prediction via class imbalance-aware ensemble learning. BMC Bioinform. 17(19), 267–276 (2016)
El-Behery, H., Attia, A.-F., El-Fishawy, N., Torkey, H.: An ensemble-based drug–target interaction prediction approach using multiple feature information with data balancing. J. Biol. Eng. 16(1), 1–14 (2022)
Niu, J., Straubinger, R.M., Mager, D.E.: Pharmacodynamic drug–drug interactions. Clin. Pharmacol. Ther.. Pharmacol. Ther. 105(6), 1395–1406 (2019)
Zhou, L., Wang, Y., Peng, L., Li, Z., Luo, X.: Identifying potential drug–target interactions based on ensemble deep learning. Front. Aging Neurosci. 15, 1176400 (2023)
Han, K., et al.: A review of approaches for predicting drug–drug interactions based on machine learning. Front. Pharmacol.Pharmacol. 12, 814858 (2022)
Jiménez-Luna, J., Grisoni, F., Schneider, G.: Drug discovery with explainable artificial intelligence. Nat. Mach. Intell. 2(10), 573–584 (2020)
Acknowledgements
This work was funded by JKSTIC DST.
Author information
Authors and Affiliations
Contributions
Basit, Idris, Injila wrote the main manuscript. Zubair and Assif prepared tabular data. Mushtaq critically reviewed it.
Corresponding author
Ethics declarations
Conflict of interest
The authors hereby declare that they have no competing interests.
Additional information
Communicated by B. Bao.
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Iqbal, A.B., Shah, I.A., Injila et al. A review of deep learning algorithms for modeling drug interactions. Multimedia Systems 30, 124 (2024). https://doi.org/10.1007/s00530-024-01325-9
Received:
Accepted:
Published:
DOI: https://doi.org/10.1007/s00530-024-01325-9